Fermentation Process Advantages and Financial Highlights
Among India's few Fermentation based Intermediate manufacturers
01
04
GTBL among one of India's few fermentation based
manufacturers in pharmaceutical field
Incorporated in 1981 as joint
sector Company with GIIC Ltd. and
Chemosyn (P) Ltd.
■ India's First Company to start
commercial production of
Antituberculosis drug Rifampicin
Product Portfolio - strong and
growing
Rifamycins Treatment of
-
Tuberculosis and digestive
tract infections
■ First to start commercial
production of Rifampicin using
Fermentation process
Focus on Research and
Development
■Company is establishing state of art
R&D facilities
■ Focus now is to develop new products
in line with business strategy
10
80
03
02
05
55
06
90
GB
State of Art Manufacturing Facility
■ Plant in Vapi (Gujarat)
■ Over 200 Employees engaged
at plant site
Strong Collaborations
■TML has been open to Technical
and commercial collaborations so
that GTBL can adopt best
technologies and best processes
Strong Financial Performance
■ 107% YoY growth in Revenues
■ Conservative Balance sheet:
Net Debt to Equity ratio - 0.06 in
FY21
■ Virtually debt free
5View entire presentation